Case series profile of olanzapine post‐injection delirium/sedation syndrome

Olanzapine pamoate is an intramuscular depot injection for the treatment of schizophrenia. Approximately 1.4% of patients develop a serious adverse event called post‐injection delirium/sedation syndrome (PDSS), characterised by drowsiness, anticholinergic and extrapyramidal symptoms. The objective i...

Descripción completa

Detalles Bibliográficos
Autores principales: Seebaluck, Jason, Downes, Michael A., Brown, Jared, Harris, Keith, Isoardi, Katherine Z., Chan, Betty S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Short Communications
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10100254/
https://www.ncbi.nlm.nih.gov/pubmed/36349832
http://dx.doi.org/10.1111/bcp.15588

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10100254/
https://www.ncbi.nlm.nih.gov/pubmed/36349832
http://dx.doi.org/10.1111/bcp.15588

Ejemplares similares